The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation

被引:157
作者
Belinky, PA
Aviram, M
Fuhrman, B
Rosenblat, M
Vaya, J
机构
[1] Migal Galilee Technol Ctr, IL-12100 Rosh Pinna, Israel
[2] Migal Galilee Technol Ctr, Lab Nat Cpds Med Use, IL-10200 Kiryat Shmona, Israel
[3] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Rambam Med Ctr, Lipid Res Lab, IL-31096 Haifa, Israel
关键词
glabridin; licorice; isoflavan; LDL oxidation; cholesteryl linoleate hydroperoxide; oxysterols; vitamin E; carotenoids;
D O I
10.1016/S0021-9150(97)00251-7
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The effect of the consumption of glabridin, an isoflavan isolated from Glycyrrhiza glabra (licorice) root, on the susceptibility of low density lipoprotein (LDL) to oxidation was studied in atherosclerotic apolipoprotein E deficient (E degrees mice) and was compared with that of the known flavonoids, quercetin and catechin. Glabridin inhibitory activity on in vitro oxidation of human LDL was also investigated by determining the formation of lipid peroxides and oxysterols and the consumption of LDL-associated lipophilic antioxidants. Determination of the extent of LDL oxidation by measuring the formation of thiobabituric acid reactive substances (TBARS) after 2 h of LDL incubation with CuSO4 (10 mu M) or 2,2'-azobis (2-amidino-propane) dihydrochloride (AAPH) (5 mM), revealed that glabridin or quercetin consumption resulted in a 53 and 54% reduction in copper ion induced oxidation, respectively, and a 95 and 83% reduction in AAPH induced LDL oxidation, respectively. No inhibition was obtained with consumption of catechin. About 80% of glabridin was found to bind to the LDL human particle. In the in vitro oxidation of LDL induced by AAPH (5 mM), glabridin inhibited the formation of TBARS, lipid peroxides and cholesteryl linoleate hydroperoxide (CLOOH) at all the concentrations tested (5-60 mu M), while in oxidation induced by copper ions (10 mu M), glabridin exhibited a pro-oxidant activity at concentrations lower than 20 mu M, and a clear antioxidant activity at concentrations greater than 20 mu M. Glabridin (30 mu M) inhibited the formation of cholest-5-ene-3,7-diol (7-hydroxycholesterol): cholest-5-ene-3-ol-7-one (7-ketocholesterol) and cholestan-5,6-epoxy-3-ol (5,6-epoxycholesterol) after 6 h of AAPH induced LDL oxidation, by 55, 80 and 40%, respectively, and after 6 h of copper ion induced LDL oxidation, by 73, 94 and 52%, respectively. Glabridin also inhibited the consumption of beta-carotene and lycopene by 38 and 52%, respectively, after 0.5 h of LDL oxidation with AAPH, but failed to protect vitamin E. The in vivo and in vitro reduction of the susceptibility of LDL to oxidation obtained with glabridin, may be related to the absorption or binding of glabridin to the LDL particle and subsequent protection of LDL from oxidation by inhibiting the formation of lipid peroxides and oxysterols, and by protecting LDL associated carotenoids. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:49 / 61
页数:13
相关论文
共 76 条
[1]
CHELATING AND FREE-RADICAL SCAVENGING MECHANISMS OF INHIBITORY-ACTION OF RUTIN AND QUERCETIN IN LIPID-PEROXIDATION [J].
AFANASEV, IB ;
DOROZHKO, AI ;
BRODSKII, AV ;
KOSTYUK, VA ;
POTAPOVITCH, AI .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (11) :1763-1769
[2]
[Anonymous], 1985, EC MED PLANT RES
[3]
ANTIOXIDANT AND PROOXIDANT PROPERTIES OF ACTIVE ROSEMARY CONSTITUENTS - CARNOSOL AND CARNOSIC ACID [J].
ARUOMA, OI ;
HALLIWELL, B ;
AESCHBACH, R ;
LOLIGERS, J .
XENOBIOTICA, 1992, 22 (02) :257-268
[4]
PLASMA-LIPOPROTEIN SEPARATION BY DISCONTINUOUS DENSITY GRADIENT ULTRA-CENTRIFUGATION IN HYPERLIPOPROTEINEMIC PATIENTS [J].
AVIRAM, M .
BIOCHEMICAL MEDICINE, 1983, 30 (01) :111-118
[5]
Aviram M, 1996, EUR J CLIN CHEM CLIN, V34, P599
[6]
AVIRAM M, 1993, ATHEROSCLEROSIS INFL, P15
[7]
THE ACTION OF DEFINED OXYGEN-CENTERED FREE-RADICALS ON HUMAN LOW-DENSITY LIPOPROTEIN [J].
BEDWELL, S ;
DEAN, RT ;
JESSUP, W .
BIOCHEMICAL JOURNAL, 1989, 262 (03) :707-712
[8]
Berg P A, 1988, Prog Clin Biol Res, V280, P157
[9]
MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN STIMULATES MONOCYTE ENDOTHELIAL INTERACTIONS [J].
BERLINER, JA ;
TERRITO, MC ;
SEVANIAN, A ;
RAMIN, S ;
KIM, JA ;
BAMSHAD, B ;
ESTERSON, M ;
FOGELMAN, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) :1260-1266
[10]
OXIDATION OF CHOLESTEROL MOIETY OF LOW-DENSITY-LIPOPROTEIN IN THE PRESENCE OF HUMAN ENDOTHELIAL-CELLS OR CU+2 IONS - IDENTIFICATION OF MAJOR PRODUCTS AND THEIR EFFECTS [J].
BHADRA, S ;
ARSHAD, MAQ ;
RYMASZEWSKI, Z ;
NORMAN, E ;
WHERLEY, R ;
SUBBIAH, MTR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 176 (01) :431-440